Perfluorooctane sulfonate (PFOS) is used extensively in industrial and household applications. High exposure to PFOS has been associated with increased odds of irregular and long menstrual cycles in women. However, the underlying mechanisms remain to be elucidated. Herein, we show that adult female mice appeared prolongation of diestrus and reduction of corpora luteum within a week of oral administration of PFOS (10 mg/kg), which are associated with decreases in the levels of serum progesterone, LH and hypothalamic GnRH. The number of AVPV-kisspeptin neurons and the AVPVkisspeptin expression were increased in proestrus mice or OVX-mice treated with high-dose estradiol benzoate (0.05 mg/kg), which were suppressed by the administration of PFOS. The administration of PFOS or GPR54 antagonist P234 prevented the generation of LH-surge in OVX-mice treated with high-dose E2. In hypothalamic slices incubated in 100 nM E2 for 4 h, the AVPVkisspeptin expression was significantly enhanced, which was inhibited by PFOS in a dose-dependent manner or estrogen receptor a (ERa) antagonist MPP, but not ERb antagonist PHTPP. The incubation of ERa agonist PPT rather than ERb agonist DPN could increase the level of AVPV-kisspeptin expression, which was sensitive to the treatment with PFOS. The administration of GPR54 agonist kisspeptin-10 in PFOS-mice could correct the prolongation of diestrus and reduction of corpora luteum, and recover the LH-surge and the levels of LH and GnRH. The results indicate that exposure to PFOS suppressed ERa-induced activation of AVPV-kisspeptin neurons leads to diestrus prolongation and ovulation reduction.
Perfluorooctanyl sulfonate (PFOS) is a degradation product of sulfonyl-based fluorochemicals that are used extensively in industrial and household applications (Renner, 2001; Seacat et al., 2002) . PFOS has been found in human serum, urine, amniotic fluid, follicular fluid, and placental tissue (Zhao et al., 2012) . PFOS is well absorbed but poorly metabolized and cleared, thus the geometric mean half-life of serum elimination of PFOS in humans has been estimated to be approximately 4.8 years (Olsen et al., 2007) . Although the exposure to PFOS has been decreased in recent years (Calafat et al., 2007) , PFOS in wildlife populations show values into tens of micromolar range (Lau et al., 2007) . The adverse effects of PFOS on female reproductive health have been recently attracting increased attention. Exposure to PFOS in the general Danish population may cause irregular menstrual periods and increased time until pregnancy (Fei et al., 2009) . A recent epidemiologic study suggested that increased exposure to PFOS is associated with higher odds of irregular and long menstrual cycles in women who plan to become pregnant (Zhou et al., 2017) . In residents with water contamination, high PFOS concentration is associated with later age of menarche (Lopez-Espinosa et al., 2011) . The exposure of adult female rats to PFOS (10 mg/kg) can disturb regular estrous cycle leading to a persistent diestrus (Austin et al., 2003) . However, the underlying mechanisms remain to be elucidated.
In females, the estrous cycle and ovarian function are controlled by hypothalamic-pituitary-gonadal (HPG) axis (Maeda et al., 2007) . Gonadotrophin-releasing hormone (GnRH) and luteinizing hormone (LH) release are regulated by feedback action of estradiol (E2) . Because GnRH neurons do not express estrogen receptor (ER), they receive the regulation of E2 largely from ER-expressing neurons elsewhere within hypothalamus, such as kisspeptin neurons in arcuate nucleus (ARC) and anteroventral periventricular nucleus (AVPV) that send projections to GnRH neurons (Roa et al., 2009) . Approximately 90% GnRH neurons express G protein-coupled receptor 54 (GPR54) that are activated by kisspeptin (Pinilla et al., 2012) . The kisspeptin-GPR54 signaling is very important for the induction of preovulatory LHsurge (Clarkson et al., 2008; Smith et al., 2006) . The exposure of adult female rats to PFOS results in a three-fold higher concentration in hypothalamus than in other brain areas (Austin et al., 2003) . A recent study reports that the treatment of adult male rats with PFOS can reduce the concentration of hypothalamic GnRH with diminution of the serum LH (Lopez-Doval et al., 2014) .
PFOS is known to have weak estrogenic activities, whereas it exerts an anti-estrogenic effect when co-administered with estradiol . PFOS has been reported to interact directly with ERa, although its binding ability to ERa is weaker than natural E2 (Benninghoff et al., 2011) . The administration of PFOS (10 mg/kg) for 2 weeks in female rats affects the food intake and energy metabolism through increasing corticosterone (CORT) (Austin et al., 2003) . In 202 human serum samples, the level of PFOS was found to be negatively correlated with triiodothyronine (T3) and thyroxine (T4) (Li et al., 2017) . Patients with hypothyroidism often show hyperprolactinemia (Watanobe and Sasaki, 1995) . Hyperprolactinemia is a major neuroendocrine related cause of reproductive disturbances in women, leading to menstrual abnormalities, infertility, and pregnancy loss (Fumarola et al., 2013) .
To explore the mechanisms underlying PFOS-disturbed estrous cycle, we examined the influence of PFOS (10 mg/kg) on the levels of reproductive hormones, CORT and thyroid hormones, the number of corpora luteum, and antral follicles in adult female mice. To determine the effects of PFOS on reproductive neuroendocrine system, we focused on the activation of AVPV-kisspeptin and ARC-kisspeptin neurons, and the generation of LH-surge. Using pharmacological methods, we further investigated the involvement of ERa/b and GPR54 in PFOSdisturbed estrous cycle. The present study provides in vivo evidence that exposure of adult female mice to PFOS (10 mg/kg) causes diestrus prolongation and ovulation reduction through suppressing the activation of ERa-mediated AVPV-kisspeptin neurons.
MATERIALS AND METHODS
Animals. Use of animals was approved by Institutional Animal Care and Use Committee of Nanjing Medical University. The animals were housed in stainless steel cages with wood bedding to minimize additional exposure to endocrine disrupting chemicals (temperature 23 6 2 C, humidity 55 6 5%, 12: 12 h light/dark cycle, and lights from 0600) in Animal Research Center of Nanjing University. They had free access to food and water. Estrous cyclicity was monitored daily at 0800-0900 using vaginal cytology, as described previously (Caligioni, 2009) . Mice that had repeated cycles of proestrus, estrus, metestrus, and diestrus in that order (4-5 days) were called "regular cyclers". Only mice with at least 4 consecutive regular estrous cycles were used in this study.
Experimental designs and administration of drugs. Twelve-week-old female ICR mice (Oriental Bio Service Inc., Nanjing), weighing approximately 30 6 2 g at beginning of all experiments, were divided into 4 experimental groups. The first group was treated with PFOS for 30 days (PFOS-mice) to examine the influence of PFOS on body weight, reproductive function and endocrine, corticosterone and thyroid hormones. PFOS (>99% purity; Sigma-Aldrich Inc., St. Louis, Missouri) was dissolved in dimethyl sulfoxide (DMSO) and diluted in 100 ll corn oil to a final concentration of 0.1% DMSO. As shown in Figure 1A , the mice were given the oral administration (p.o.) of PFOS (10 mg/kg) for 30 days, because this dose of PFOS has been reported to cause a persistent diestrus (Austin et al., 2003) . Body weight and estrous cycles were monitored daily. The hormonal levels, ovarian morphology and kisspeptin neurons were examined on day 7 and day 14 of PFOS-exposure, respectively. In the second group ( Figure 1B) , the mice anesthetized with chloral hydrate (400 mg/ kg, i.p.) were ovariectomized (OVX) bilaterally. At days 6-7 after OVX, the vaginal smear was examined to determine if the surgery was successful (Ng et al., 2010) , and then silastic capsule containing 0.625 lg E2 (Sigma-Aldrich Corp.) was implanted for 4 days (low-dose E2, Ld-E2). After the silastic capsule was taken out, the mice received injection of estradiol benzoate (0.05 mg/ kg; s.c., Sigma-Aldrich) for 2 days (high-dose E2, Hd-E2) to produce a preovulatory E2 level and LH-surge (Quennell et al., 2011) . The OVX mice treated with Hd-E2 were given the coadministration of PFOS (10 mg/kg, o.p.) or GPR54 antagonist peptide 234 (P234, Sigma-Aldrich Corp., 5 nmol/mouse, i.c.v., Roseweir et al., 2009) for 2 days to examine the influence of PFOS on E2-activated AVPV-kisspeptin neurons and GnRH neurons, and LH-surge. For intra-cerebroventricular (i.c.v.) injection, mice were anesthetized with chloral hydrate and were then placed into a stereotaxic instrument (Stoelting, Wood Dale, Illinois). A small hole (2 mm diameter) was drilled in skull using a dental drill and a 26-G stainless steel guide cannula (Plastics One, Roanoke, Virginia) was implanted into right lateral ventricle (anteroposterior þ0.2 mm, lateral þ0.8 mm, dorsoventral 2.5 mm) and anchored to the skull with three stainless steel screws and dental cement. P234 was dissolved in 0.1% DMSO and injected (i.c.v., 3 ll) using a stepper-motorized micro-syringe (Stoelting, Wood Dale, Illinois). The mice injected with vehicle (0.1% DMSO) at the same volume served as the control group. In the third group ( Figure 1C ), the OVX mice treated with Ld-E2 for 4 days were anesthetized (chloral hydrate) and decapitated. The hypothalamic slices (400 lm) were cut using a vibrating microtome (Microslicer DTK 1500, Dousaka EM Co, Kyoto, Japan) in ice-cold artificial cerebrospinal fluid (ACSF) (in mM: 126 NaCl, 1 CaCl2, 2.5 KCl, 1 MgCl2, 26 NaHCO 3 , 1.25 KH 2 PO 4 , and 20 D-glucose, pH 7.4) oxygenated with a gas mixture of 95% O2/ 5% CO 2 . The hypothalamic slices were incubated for 4 h with E2 (100 nM; Kelly et al., 2002) , PFOS (100 lM; Kjeldsen and BonefeldJorgensen, 2013) , PPT (1 lM), DPN (1 lM), MPP (10 lM; Harrington et al., 2003) , and PHTPP (10 lM; Compton et al., 2004) to the determine molecular targets of PFOS actions in E2-activated AVPVkisspeptin neurons. ERa agonist PPT, ERb agonist DPN, ERa antagonist MPP, and ERb antagonist PHTPP were purchased from Tocris Cookson Ltd. (Avonmouth, UK) and dissolved in DMSO and diluted by ACSF to a final concentration of 0.1% DMSO. Control group were treated with vehicle (0.1% DMSO). The fourth group was used to further confirm the relationship between the PFOS-suppressed AVPV-kisspeptin neurons and the diestrus prolongation. As shown in Figure 1D , PFOS-mice were treated with the injection (i.c.v.) of GPR54 agonist kisspeptin-10 (1 nmol/mouse, Gottsch et al., 2004) starting from day 7 of PFOS-exposure for 7 days. Kisspeptin-10 (Sigma-Aldrich Corp.) were dissolved in DMSO, and then diluted in 0.9% saline. The mice injected with vehicle (0.1% DMSO) at the same volume served as the control group.
Measurement of PFOS.
Blood samples were collected from control mice and PFOS-mice ( Figure 1A ). PFOS was measured at the Shanghai Key Laboratory of Children's Environmental Health, China (Zhou et al., 2017) . Concentrations of PFOS were detected from 100 ll plasma using the high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS-MS) (Agilent 1290-6490, Agilent Technologies Inc.). After thawed at 4 C, the plasma sample was vortexed with 10 ll of 50 ng/ml internal standard solution for 30 s. About 150 ll methanol was added before the second vortex. The third vortex was carried out after 150 ll acetonitrile of 1% formic acid was added. The mixture was sonicated for 20 min and centrifuged at 12 000 rpm for 10 min. The supernatant was collected and filtered through a 0.22 lm nylon syringe filter into a 1.5 ml auto-sampler vial. The calibration standard and quality control material were prepared by spiking blank fetal bovine serum with the standard mixture of the 10 analytes. Internal standards labeled by carbon isotope were added before extraction. The quality control samples were indistinguishable from the plasma samples, and the lab technicians were blinded to the subject information. The limit of detection (LOD) for PFOS was 0.09 ng/ml.
Ovarian morphology. Mice on diestrus were anaesthetized with chloral hydrate ( Figure 1A ). Ovaries were dissected and fixed in Bouin's fluid. After dehydration through a graded series of alcohol, the samples were processed for paraffin embedding and sections (5 lm) were serially cut. The sections were deparaffined and rehydrated, and then stained with hematoxylin and eosin (HE). Antral follicles were scored in every 6 th section (30 mm apart). Then, the number of antral follicles was multiplied by 6 to give a total number in each ovary. The number of corpora luteum was scored in a blinded fashion using one section per ovary and one ovary per mouse (Glidewell-Kenney et al., 2007) .
Measurement of serum hormones and hypothalamic GnRH. To examine LH-surge generation, orbital blood (60 ll per time) was obtained at proestrus 1300, 1600, 1700, and 1800. An equivalent volume of normal saline was replaced through the caudal vein after each blood collection. Serum was separated by centrifugation at 4 C and stored at À80 C until assay. The commercial enzyme-linked immunosorbent assay (ELISA) kits (Uscn Life Science Inc., Houston, Texas,) were used to measure the levels of serum CORT, T3, T4, E2, progesterone (P4), and LH. The measurement of each sample was repeated 2 times to obtain an average value. The sensitivities were 0.51 ng/ml for CORT, 51.7 pg/ml for T3, 1.29 ng/ml for T4, 4.45 pg/ml for E2, 0.47 ng/ml for P4, and 145.2 pg/ml for LH, respectively. Mice were decapitated and brains were taken quickly. Coronal sections of brain (0.6 mm thick, from bregma þ0.62 to þ0.02 mm) (Paxinos and Franklin, 1997) were cut using a cryostat. Tissue containing POA was punched-out (laterally 2 mm of third ventricle) with a biopsy needle (1.5 mm in diameter, Kai Industries Co., Ltd., Gifu, Japan) on dry ice and stored at À80 C until use. The GnRH concentration was examined using an ELISA kit (Uscn Life Science Inc., Houston, Texas) as described previously ( Immunohistochemistry of kisspeptin neurons. Control mice and PFOS-mice were anesthetized with chloral hydrate ( Figure 1A ) and perfused transcardially with 4% paraformaldehyde. After brains were post-fixed overnight, brains were transferred gradually into 15% and 30% sucrose until they settled. Sections (30 lm thick) were cut using a cryostat. Free-floating sections were incubated in 0.5% sodium metaperiodate for 20 min and then in 1% sodium borohydride for 20 min. The sections were preincubated with 1% normal fetal goat serum for 60 min, and then incubated in rabbit anti-kisspeptin polyclonal antibody (1:1000, Catalog# AB9754, Millipore, Billerica, Massachusetts) for 24 h at 4 C. Then, the sections were treated with biotin-conjugated goat anti-rabbit IgG (1:400; vector laboratories, Burlingame, Calfornia) for 2 h at 37 C. The immune-reactivity was visualized with the standard avidin-biotin complex reaction with Ni-3, 3-diaminobenzidine (DAB, Vector Laboratories). The kisspeptin positive (kisspeptin þ ) cells in AVPV (8 sections, from bregma þ0.62 to þ0.02 mm) were counted under conventional light microscope (Olympus DP70; Olympus, Tokyo, Japan) with a 40Â objective. Because there were very dense kisspeptin þ fiber plexuses in ARC, it is difficult to correctly count the kisspeptin þ cells in this nucleus. Thus, we in this study measured the optical density of ARC kisspeptin-immunoreactivity (15 sections, from bregma À1.22 to À2.80 mm) (Paxinos, 1997) using ImageJ (NIH) (Overgaard et al., 2013) .
Western blot analysis. Mice were decapitated and brains were removed quickly. Coronal sections of brain containing AVPV (0.6 mm thick, from bregma þ0.62 to þ0.02 mm) and ARC (1.6 mm thick, from bregma À1.22 to À2.80 mm) (Paxinos, 1997) were obtained using a cryostat. The regions of AVPV (laterally 0.5 mm of the third ventricle) and ARC (laterally 0.8 mm of the third ventricle) were then isolated using a biopsy needle (1.5 mm diameter) (Gill et al., 2010) . Proteins (25 lg) were loaded in each lane for separation in sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto nitrocellulose membranes. Blotting membranes were incubated with blocking solution (5% nonfat dried milk) for 1 h at room temperature, and then incubated with a goat antikisspeptin polyclonal antibody (1:200; Catalog# sc-18134, Santa Cruz Biotechnology, California) at 4 C overnight. After washed, the membranes were incubated for 1 h with HRP-labeled rabbit anti-goat IgG (1:2000; Abcam, Cambrigde, UK). The Western blot bands were scanned and analyzed with the image analysis software package (ImageJ).
Reverse transcription, quantitative polymerase chain reaction (RTqPCR). Total RNA was isolated from hypothalamus AVPV and ARC regions using Trizol reagent (Invitrogen, Camarillo, California), and then reverse-transcribed into cDNA using a Prime Script RT reagent kit (Takara, China) for Quantitative PCR (ABI Step One Plus, Foster City, California) in the presence of a fluorescent dye (SYBR Green I; Takara). The relative expression of genes was determined using the 2 -DDct method with normalization to GAPDH expression. The primer sequences of Kiss1 and Gapdh mRNA were designed as described previously (Xi et al., 2011) .
Data analysis/statistics. The group data were expressed as the means 6 standard error (SE). All statistical analyses were performed using SPSS software, version 16.0 (SPSS Inc., Chicago, Illinois). Differences among means were analyzed using one-or two-way ANOVA followed by Bonferroni post hoc analysis. Differences at p < .05 were considered statistically significant.
RESULTS

Influence of PFOS on Reproductive Capacity and Endocrine
In comparison with control mice (0.531 ng/ml), the level of serum PFOS (median 3206 ng/ml) was elevated by the administration of PFOS (10 mg/kg) for 14 days (n ¼ 20). Two-way ANOVA with repeated-measures revealed that the body weight was affected by PFOS exposure (F (1, 456) ¼ 38.103, p < .001; Figure 2A ) and PFOS exposure Â time (F (11, 456) ¼ 2.142, p ¼ .017). The PFOS exposure caused a progressive decline of body weight starting from day 14 of PFOS-exposure (p < .05).
As shown in Figure 2B , an obvious prolongation of diestrus (D) was observed within a week of PFOS-exposure (mean of 30 days PFOS-exposure, p < .01, n ¼ 20), while the duration of proestrus (P), estrus (E) or metestrus (M) was unchanged (p > .05).
Histological examination of ovaries on day 7 of PFOSexposure ( Figure 2C ) showed a significant decrease in the number of corpora luteum (p < .05, n ¼ 8; Figure 2C -i) without change in the number of antral follicles (p > .05, n ¼ 8; Figure 2C -ii).
The levels of serum E2, P4, LH, CORT, T3, T4, and hypothalamic GnRH were examined on day 7 and day 14 of PFOSexposure, respectively ( Figure 1A , n ¼ 8 per experimental group). In comparison with controls, the levels of P4 (day 7: p < .05; day 14: p < .01; Table 1), LH (day 7: p < .01; day 14: p < .05) and GnRH (day 7/14: p < .01) were reduced. The decline of E2 (p < .05) was observed on day 14 of PFOS-exposure. The elevation of CORT (p < .05) or the reduction of T4 (p < .05) and T3 (p < .05) were found on day 14 of PFOS-exposure.
Influence of PFOS on the Activities of Kisspeptin Neurons
The GnRH neurons receive the regulation of E2 largely from hypothalamic kisspeptin neurons. The responses of hypothalamic AVPV-kisspeptin neurons and ARC-kisspeptin neurons to E2 are different: the high level of E2 on proestrus enhances the activation of AVPV-kisspeptin neurons, but suppresses the ARCkisspeptin neurons (Dungan et al., 2006) . Because the levels of GnRH and LH were reduced from day 7 of PFOS-exposure, we further examined the activity of hypothalamic AVPV-and ARCkisspeptin neurons ( Figure 1A , n ¼ 8 per experimental group). The number of AVPV-kisspeptin þ cells ( Figure 3A ) or the levels of AVPV-Kiss1 mRNA ( Figure 3B ) and AVPV-kisspeptin protein ( Figure 3C) (p < .01), the levels of AVPV-Kiss1 mRNA (p < .01) and AVPVkisspeptin protein (p < .01) on proestrus were higher than those on diestrus. In comparison with controls, the number of AVPVkisspeptin þ cells (p < .05), the levels of AVPV-Kiss1 mRNA (p < .01) and AVPV-kisspeptin protein (p < .05) on proestrus were significantly reduced in PFOS-mice, whereas on diestrus had no significant difference between control mice and PFOS-mice (p > .05).
In contrast, the ARC-kisspeptin immuno-reactivity ( Figure 3D ) or ARC-Kiss1 mRNA ( Figure 3E ) and ARC-kisspeptin protein ( Figure 3F) kisspeptin immuno-reactivity (p < 0.01), the levels of ARC-Kiss1 mRNA (p < .01) and ARC-kisspeptin protein (p < 0.05) on proestrus were lower than those on diestrus. However, the ARCkisspeptin immuno-reactivity (p > .05), the level of ARC-Kiss1 mRNA (p > .05) and ARC-kisspeptin protein (p > .05) in PFOSmice did not differ significantly from control mice. The results indicate that exposure to PFOS on proestrus suppresses the E2-increased AVPV-kisspeptin expression.
Influence of PFOS in E2-Increased AVPV-Kisspeptin Expression and E2-Triggered LH Surge
To determine the inhibitory effect of PFOS on E2-increased AVPV-kisspeptin expression, we prepared a mice model of E2-increased AVPV-kisspeptin expression and E2-induced generation of LH surge (Quennell et al., 2011) . The OVX-mice were treated with the administration of Ld-E2 (0.625 lg, s.c.) for consecutive 4 days ( Figure 1B ) to produce a level of diestrus E2 measured in intact mice (p > .05, n ¼ 8; Figure 4A ), followed by the treatment with Hd-E2 (estradiol benzoate, 0.05 mg/kg, s.c.) for further 2 days to reach a level of proestrus E2 (p > .05, n ¼ 8).
In comparison with the OVX mice treated with Ld-E2, the administration of Hd-E2 significantly increased the levels of AVPV-Kiss1 mRNA (p < .01, n ¼ 8; Figure 4B ), AVPV-kisspeptin protein (p < .01, n ¼ 8; Figure 4C ) and hypothalamic GnRH (p < .01, n ¼ 8; Figure 4D) . Notably, the treatment with PFOS (10 mg/kg) evidently suppressed the Hd-E2-induced increases in the levels of AVPV-Kiss1 mRNA (p < .01, n ¼ 8), AVPV-kisspeptin protein (p < .01, n ¼ 8) and GnRH (p < .05, n ¼ 8). Furthermore, the application (i.c.v.) of GPR54 antagonist P234 (5 nmol/mouse) could suppress the Hd-E2-induced increase in the level of GnRH (p < .01, n ¼ 8).
As shown in Figure 4E , the administration of Hd-E2 was able to induce a surge-like increase in serum LH level (LH-surge), which was inhibited by the treatment with PFOS or P234 (n ¼ 8).
The results further confirm that exposure to PFOS directly suppresses the E2-activated AVPV-kisspeptin neurons to inhibit the generation of LH-surge.
Molecular Targets of PFOS Action in E2-Activated AVPV-Kisspeptin Expression
The hypothalamic slices were obtained from OVX-mice treated with Ld-E2. After the slices were treated with 100 nM E2 for 4 h ( Figure 1C , n ¼ 8 slices per experimental group), the level of AVPV-Kiss1 mRNA was elevated about 8 times (p < .01; Figure 5A ). The E2-induced increase in the AVPV-Kiss1 mRNA was inhibited by the application of PFOS in a dose-dependent manner (F (5, 49) ¼ 29.979, p < .001). The ERa agonist PPT (1 lM) could evidently increase the level of AVPV-Kiss1 mRNA (p < 0.01; Figure 5B ), but the ERb agonist DPN (1 lM) did not (p > .05). The enhancing effect of E2 on the AVPV-Kiss1 mRNA could be blocked by the ERa antagonist MPP (10 lM, p < .01) rather than the ERb antagonist PHTPP (10 lM, p > .05). Similarly, the addition of PFOS (100 lM) could suppress the PPT-induced increase of AVPV-Kiss1 mRNA (p < .01). The results indicate that PFOS suppresses the ERa-mediated activation of AVPV-kisspeptin neurons.
Involvement of PFOS-Suppressed AVPV-Kisspeptin in Reproductive Endocrine and Function
To confirm the association of PFOS-suppressed AVPV-kisspeptin neurons with the prolongation of diestrus, the ovulation failure and decline of reproductive hormones, PFOS-mice were treated with the application (i.c.v.) of GPR54 agonist kisspeptin-10 starting from day 7 of PFOS-exposure ( Figure 1D , n ¼ 8 per experimental group). In comparison with PFOS-mice treated with vehicle, the treatment of PFOS-mice with kisspeptin-10 corrected the prolongation of diestrus (p < .01; Figure 6A ), the reduction of corpora luteum (p < .01; Figure 6B ), the decline of P4 (p < .01; Figure 6C ) and LH (p < .01; Figure 6D ). Moreover, the administration of kisspeptin-10 in PFOS-mice recovered the generation of LH-surge (n ¼ 8, Figure 6E ).
DISCUSSION
The present study provides in vivo evidence that exposure of adult female mice to PFOS (10 mg/kg) through suppressing AVPV-kisspeptin neurons leads to diestrus prolongation and ovulation reduction. Austin et al. (2003) reported that the administration of PFOS (10 mg/kg) for 2 weeks in female rats causes the diestrus prolongation and the reduction of the food intake through increasing CORT level. The abnormal energy metabolism can disturb the reproductive endocrine function (Kirby et al., 2009) . However, it is unlikely that it contributes to the diestrus prolongation and ovulation reduction in PFOS-mice, because the occurrence of high CORT and low body weight were later than the reproductive phenotypes. Similarly, the levels of T3 and T4 were reduced by 2-weeks administration of PFOS. Furthermore, the E2-induced increases in AVPV-kisspeptin expression and the GnRH level or the generation of LH-surge were distinctly suppressed by the acute in vivo or in vitro treatment with PFOS.
PFOS Suppresses Rapidly AVPV-Kisspeptin Neurons
A principal observation in this study is that exposure of adult female mice to PFOS can suppress the AVPV-kisspeptin neurons, as suggested by the following results: (1) The AVPV-kisspeptinþ cells, levels of AVPV-Kiss1 mRNA and AVPV-kisspeptin protein on proestrus were significantly decreased in PFOS-mice, whereas the ARC-kisspeptin expression on proestrus or diestrus had no significant difference between PFOS-mice and control mice. (2) The kisspeptin binding to GPR54 expressing in GnRH neurons enhances the release and expression of GnRH (Stathatos et al., 2005; Strock and Diverse-Pierluissi, 2004) . The levels of LH and GnRH in PFOS-mice were reduced compared to controls, which were corrected by the administration of kisspeptin-10. (3) The "E2-induced positive feedback" in AVPVkisspeptin neurons on proestrus is critical for the LH-surge generation. We have recently reported that the exposure to low dose of PFOS (0.1 mg/kg) for 4 months in adult female mice causes a prolongation of diestrus, but does not alter the body weight (Feng et al., 2015) . The chronic exposure to low dose of PFOS suppresses the expression of ovarian steroidogenic acute regulatory (StAR) through selectively reducing histone H3K14 acetylation of StAR promoter leading to the decline of the E2 biosynthesis. The decline of E2 level on proestrus leads to the reduction in the level of AVPV-kisspeptin expression. By contrast, the decreases in the AVPV-kisspeptin expression or the levels of GnRH and LH on day 7 of the PFOS (10 mg/kg)-exposure was not associated with the change in the E2 level. Thus, the reduction of AVPV-kisspeptin expression in PFOS-mice is unlikely due to the E2 deficiency. In the OVX-mice, E2 induced increases in the AVPV-kisspeptin expression and the levels of GnRH and LH were suppressed by the administration of PFOS. (4) Several studies provide evidence to support that the activity of AVPVkisspeptin neurons on proestrus is critical for the generation of LH surges (Ishii et al., 2013) . The increase of AVPV-kisspeptin expression on proestrus reaches the highest at 1500, around the time of LH-surge peak . PFOS could inhibit the amplitude of LH-surge induced by the high-dose E2, which could be rescued by the administration of kisspeptin-10. Furthermore, the blockade of GPR54 by P234 could prevent the production of LH-surge in control mice.
PFOS Suppresses Rapidly AVPV-Kisspeptin Neurons via ERa Antagonist
The activation of AVPV-kisspeptin neurons on proestrus depends on the E2-positive regulation (Smith et al., 2006) . Consistent with an earlier study (Wang et al., 2014) , the shortterm (for 4 h) treatment of the slices with E2 increased obviously the level of AVPV-Kiss1 mRNA, which was blocked by ERa antagonist, but not ERb antagonist. In addition, the ERa agonist rather than the ERb agonist could mimic the E2-positive regulation in AVPV-Kiss1 mRNA. Thus, it is conceivable that the activation of ERa is important for the E2-enhanced transcription of AVPVkisspeptin. The E2-induced or ERa-mediated AVPV-kisspeptin expression was attenuated by the addition of PFOS. Benninghoff et al. (2011) have reported the PFOS weakly binding to ERa. Thus, it is highly likely that the exposure to high dose PFOS (10 mg/kg) suppresses the AVPV-kisspeptin neurons through the inactivation of ERa. PFOS is known to have weak estrogenic activities, whereas exerts an anti-estrogenic effect when co-administered with E2 . Although xenobiotics heptachlor is not a potent competitor with E2 for the ER, it can inhibit the response of rainbow trout hepatocytes to E2 through co-exposure to E2 (Okoumassoun et al., 2002) . In addition, some natural and synthetic estrogens have been reported to induce conformational changes in the tertiary structure of ERa (Paige et al., 1999) . Because PFOS has the amphipathic nature, the perfluorinated compound is thought to cause conformational alterations in the ligand binding site (Jones et al., 2003) . Further investigations are required to clarify the details. Two major mechanisms are involved in ERa-mediated transcriptional gene regulations. One classical signaling is that ERa directly binds to estrogen responsive elements (EREs) located in the promoter region of target genes to alter gene transcription. The stimulation of AVPV-kisspeptin expression by E2 depends on an ERE-dependent pathway, while the inhibition of ARCkisspeptin expression by E2 involves ERE-independent mechanisms (Gottsch et al., 2009) . Other non-classical signaling involves the ERa-mediated gene expression by interacting with other transcription factors such as c-Fos, AP-1 and Sp1, which in turn can associate with target DNA elements to induce transcriptional activation (Fleming et al., 2006; Safe and Kim, 2004) . The Kiss1 promoter contains Sp1 elements within the first 200 bp (Mitchell et al., 2007) . The administration of PFOS failed to affect the ARC-kisspeptin expression on proestrus or diestrus. A possible reason might be that the ratio of ERa to ERb in ARCkisspeptin neurons is less than that in AVPV-kisspeptin neurons (Smith et al., 2005) . To resolve this problem, further study would be required.
PFOS Affects Estrous Cycle and Ovulation via Suppression of AVPVKisspeptin Neurons
Estrous cyclicity is controlled by the two modes of GnRH/LH release: one is a tonic or pulse release that is responsible for the stimulation of follicular development and steroidogenesis; another is a LH-surge release that is responsible for ovulation (Maeda et al., 2007) . The endogenous kisspeptin plays a critical role in controlling the reproductive endocrine axis, ovulation and estrous cycle. The infusion of kisspeptin antibody into the POA can reduce the levels of E2 and LH to produce a persistent diestrus (Gottsch et al., 2009; Kinoshita et al., 2005) . The application of kisspeptin-10 in PFOS-mice could prevent the prolongation of diestrus. Thus, it is highly likely that the reduced AVPV-kisspeptin in PFOS-mice is able to disturb the regular estrous cycle. Moreover, the application of kisspeptin-10 could correct the reduction of corpora luteum, the decline of P4 and LH and recovered the generation of LH-surge in PFOS-mice. Le et al. (2001) reported that the delayed and attenuated LH-surge may be a direct cause of female reproductive senescence. In summary, our results in the present study give a clear indication that exposure of adult female mice to PFOS (10 mg/kg) can impair the reproductive capacity through suppressing the AVPV-kisspeptin expression. Our results showed that the administration of PFOS (10 mg/kg) for 14 days produced a serum level of 3206 ng/ml in mice. An American study from the DuPont Washington Works Plant near Parkersburg (Knox et al., 2011) reported that the median PFOS level was 15.0 ng/ml in women aged 18-42 (n ¼ 13 458). Meanwhile, the median and interquartile range of PFOS in preconception women in Shanghai, China (2013 were recently reported to be 10.49 (7.55-15.37) ng/ml (Zhou et al., 2017) . In particular, the occupational exposure in fluorochemical manufacturing workers leads to their serum levels to be higher than 12.8 lg/ml (Giesy and Kannan, 2002) . The mean half-lives of PFOS in human serum have been estimated to be approximately 4.8 years (Olsen et al., 2007) . The exposure of adult female mice to PFOS (0.1 mg/kg/ day) produced a gradual increase in serum PFOS levels from 4th month (2481.11 ng/ml) to 6th month (4013.29 ng/ml) (Feng et al., 2015) . Although the exposure of PFOS has been decreased in recent years (Calafat et al., 2007) , average level of serum PFOS in human has been reported to range from 145 to 3490 ng/ml (Olsen et al., 2007) . In addition, human blood contains several perfluorinated compounds such as perfluorooctanoic acid, which are thought to have similar effects as those of PFOS (Hansen et al., 2001; Olsen et al., 2000) . Therefore, it is timely and important to evaluate the adverse effects of PFOS on women's reproductive health.
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